New study aims to keep HIV patients on track after prison release
NCT ID NCT06027671
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a program called Full-SPARCS, where trained peers lead group sessions to help people with HIV stay in care after they leave prison in South Africa. The program includes one-on-one check-ins and group meetings in community centers. Researchers will compare viral suppression rates at 6 and 12 months between those in the program and those receiving usual care. 400 participants are being recruited from correctional facilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- peer-led support group program (Full-SPARCS)
- What this could lead to
- If it works, this could provide a practical, scalable way to help people with HIV stay healthy after leaving prison, reducing viral spread and improving long-term outcomes.
- What could go wrong
- This is a behavioral intervention, not a new drug, so results may vary by setting. The study is still recruiting, and success depends on participants attending group sessions and staying engaged.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Aurum Institute - Head office
RECRUITINGJohannesburg, Gauteng, 2193, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Can Long-Acting HIV shots outperform daily pills during lymphoma treatment?
- Immune-Boosting cocktail aims to free HIV patients from daily medication